MANKINDMankind Pharma Limited
Pharma · Drug Manufacturers - Specialty & Generic · NSE · as of 2026-07-20 (delayed ~30 min in market hours)
₹2,565.80
▲ 3.28%Strong
Price & Volume
Loading chart…
Key Ratios
Market Cap (₹ cr)1,04,533.40
P/E54.56
P/B6.41
PEG1.72
ROE %12.45
ROCE %12.50
Debt / Equity0.38
EPS46.39
Revenue Growth %11.80
Profit Growth %31.70
Dividend Yield %0.04
Promoter Holding %75.40
FII Holding %20.01
DII Holding %—
Beta0.45
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
| Pullback to 21-EMA | LONG | 78% | ₹2,565.80 | ₹2,469.50 | ₹2,700.30 | 1.40 |
BUYConviction 83%
Why buy
- • Profit growth: 31.7% YoY
- • Debt/Equity: 0.38
- • Promoter holding: 75.4%
- • RSI: 60
- • Price vs EMA21: above
- • Price vs SMA50: above
- • Pullback to 21-EMA signal (setup quality 78%)
Bull case
- • Profit growth: 31.7% YoY
- • Debt/Equity: 0.38
- • Promoter holding: 75.4%
- • RSI: 60
Bear case
- • Dividend yield: 0.04%
- • MACD: bearish
- • Volume trend: 0.8x baseline
Key risks
- • Dividend yield: 0.04%
- • MACD: bearish
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Entry (CMP)
₹2,565.80
Stop Loss
₹2,432.43
risk 5.2%
Target 1 (1.5R)
₹2,765.86
+7.8%
Target 2 (3R)
₹2,965.91
+15.6%
Support (20d)
₹2,457.00
Resistance (52w)
₹2,715.43
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹133.37/share
ATR (volatility)
₹67.67
avg daily range
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹67.67). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.
Score Breakdown
Fundamental
64
Technical
76
Momentum
79
Risk (safety)
74